"Pentazocine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)
| Descriptor ID |
D010423
|
| MeSH Number(s) |
D03.132.577.249.106.700 D04.615.723.795.106.700
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pentazocine".
Below are MeSH descriptors whose meaning is more specific than "Pentazocine".
This graph shows the total number of publications written about "Pentazocine" by people in this website by year, and whether "Pentazocine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pentazocine" by people in Profiles.
-
Kim FJ, Kovalyshyn I, Burgman M, Neilan C, Chien CC, Pasternak GW. Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol. 2010 Apr; 77(4):695-703.
-
Gedde S, Regillo CD, Vander J. Advanced proliferative retinopathy and iris neovascularization in an intravenous drug abuser. Ophthalmic Surg. 1995 Jan-Feb; 26(1):85-7.